InGen BioSciences Group, Exclusive Distributor for Cylex …PR Newswire (press release)Cainelli F., Vento S. Infections and solid organ transplant rejection: a … Using an immune functional assay to differentiate acute cellular rejection from recurren…
InGen BioSciences Group, Exclusive Distributor for Cylex Incorporated in France, Reinforces its Translational Medicine …
CHILLY-MAZARIN, France, June 14, 2012 /PRNewswire/ –InGen BioSciences, specialised in the development and commercialisation of mono and multiparametric in vitro diagnostic tests announced a new exclusive …
Seattle Genetics updates survival data from Adcetris trial for Hodkin lymphoma
Seattle Genetics announced updated survival data from a pivotal clinical trial of single-agent ADCETRIS in patients with relapsed or refractory Hodgkin lymphoma after autologous stem cell transplant showing …
Seattle Genetics Highlights Updated Survival Data from ADCETRIS® Pivotal Trial in Patients with Relapsed or Refractory …
Seattle Genetics, Inc. today announced updated survival data from a pivotal clinical trial of single-agent ADCETRIS in patients with relapsed or refractory Hodgkin lymphoma after autologous stem cell transplant showing that the median overall survival …
Nature：AMPK酶在癌症中的双重作用 – 生物谷 (新闻发布)
生物谷 (新闻发布)Nature：AMPK酶在癌症中的双重作用生物谷 (新闻发布)趋化因子及受体CCL5/CCR5促进乳腺癌转移 · Cancer Res：蛋白质RAL与肿瘤的侵袭性特征有关 · J Biol Chem：方靖等揭示FOX…
Scientists grow new vein from girl's stem cell – Business Standard
Scientists grow new vein from girl's stem cellBusiness StandardFor the first time, scientists led by an Indian-origin researcher have successfully replaced a major blood vessel in a 10-year-old girl with a vein grown in a lab using her own stem cel…
@IU_Health draws big audience for transplant
As two Sullivan County men went through a life-saving kidney transplant on Wednesday, a worldwide audience checked in online to follow the progress of the surgery and ask questions of the medical team via Indiana’s first “Twittercast” of a live s…
Updated survival data from Takeda’s brentuximab vedotin Phase II trial on HL
Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced updated survival data from a pivotal Phase II clinical trial of single-agent brentuximab vedotin in patients with relapsed or r…
'So I’m living for today'
Seven years ago, Justine Laymond lay on a hospital bed on life-support. After a double lung transplant, the 39-year-old British woman is a crew member on Edinburgh Inspiring Capital, the Scottish entrant in the Clipper Round the World Yacht Race. (CHRI…
Voluntary blood donation need of the hour – The Hindu
Zee NewsVoluntary blood donation need of the hourThe HinduLack of idea on medical and health benefits of donating blood or non-dissemination of knowledge on absence of any side effects in a healthy eligible male, …City people still hesitate in blood …